Docoh
Loading...

37 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
PRPO Precipio Inc
12 Nov 21
Quarterly report
4:02pm
, the Omaha facility is designed to expand our proficiencies and knowledge in transitioning R&D lab generated technology into a commercial laboratory … environment. Capitalizing on this strategy, during the end of the third quarter 2020, we transitioned our HemeScreen technology from the R&D facility
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
. Functioning side-by-side as a CLIA operating laboratory, the Omaha facility is designed to expand our proficiencies and know-how in transitioning R&D lab … our HemeScreen technology from the R&D facility to the commercial laboratory setting launching the HemeScreen Reagent Rental (HSRR) program. HSRR
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
laboratory, the Omaha facility is designed to expand our proficiencies and know-how in transitioning R&D lab generated technology into a commercial … laboratory environment. Capitalizing on this strategy, during the end of the third quarter 2020, we transitioned our HemeScreen technology from the R&D facility
DEF 14A
PRPO Precipio Inc
29 Apr 21
Definitive proxy
4:31pm
Carl R. Iberger,(4) Chief Financial Officer Ahmed Zaki Sabet,(5) Chief Operations Officer Ayman A. Mohamed,(6) VP R&D The amounts in this column … was appointed our VP R&D effective June 29, 2017. Prior to that, Mr. Mohamed was the Chief Technology Officer of Precipio Diagnostics, Inc. since November
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
to process a variety of commercial molecular tests previously referenced out and to further expand our capabilities and “know-how” in transitioning R&D lab
10-K
i9zhio8v7zs
29 Mar 21
Annual report
4:29pm
8-K
EX-99.1
dn70zkje6gchcmwlwm
16 Oct 18
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
4:41pm
8-K
19t1jv09 kj8
9 Aug 18
Precipio Appoints New Board Member to Replace Departing Director
4:31pm
8-K
EX-10.1
q9iqnf0a
9 Aug 18
Precipio Appoints New Board Member to Replace Departing Director
4:31pm
S-1
yau4i
15 Apr 18
IPO registration
8:00pm
10-K
jz9t0opv
12 Apr 18
Annual report
8:00pm
8-K
EX-99.1
3crjjhkv41218
20 Nov 17
Precipio Announces Third Quarter 2017 Financial Results and Provides Corporate Update
7:00pm
8-K
EX-99.1
5vsh3uj41rjld1
13 Nov 17
Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director
7:00pm
8-K
EX-99.1
99k4rhi3olujk5g
12 Nov 17
Precipio, Inc. Announces Closing of $2,748,000 Registered Direct Offering
7:00pm
8-K
EX-99.1
xu0q vjax19vm0p5cv
7 Sep 17
Precipio Provides Shareholder Update Letter
8:00pm
FWP
y8nok38dqlty71x
1 Aug 17
Free writing prospectus
8:00pm
FWP
wkqtnrgr0t93 bkdm
31 Jul 17
Free writing prospectus
8:00pm
8-K
EX-99.1
i84k0nolyi4 b1a77jo
29 Jun 17
Precipio Diagnostics and Transgenomic Complete Merger
8:00pm
DEFM14A
lvs rv8s8for
11 May 17
Proxy related to merger
8:00pm
PRER14A
0nkucfhzlfddjh8 ij
7 May 17
Preliminary revised proxy
8:00pm